Company intelligence / Profile preview

Medistim

Oslo, Oslo County, Norwaymedistim.com ↗

Ownership: Public · MEDI
Employees: ~160
Development stage: Other

Overview

Medistim’s devices are considered standard-of-care for intraoperative blood flow measurement and vessel visualization in many European countries and Japan. Clinical studies support their efficacy in improving surgical outcomes by providing real-time data to surgeons during cardiac, vascular, and transplant procedures. The company continues to expand its market presence globally with growing adoption rates.

Therapeutic areas: CardiovascularOther
Modalities: DeviceUltrasound imaging deviceTransit time flow measurement device (TTFM)
Industry: Medical Imaging

Partnerships

Distributes products from about 100 medical technology companies within Scandinavia as a third-party distributor

Financials

Market cap: $22.6M
Enterprise value: $22.6M

Beyond the preview

Go deeper on Medistim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medistim.

Explore the full profile